Entity Common Stock, Shares Outstanding of Ascendis Pharma A/S from 31 Dec 2017 to 31 Dec 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Ascendis Pharma A/S quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 31 Dec 2017 to 31 Dec 2025.
  • Ascendis Pharma A/S Entity Common Stock, Shares Outstanding for the quarter ending 31 Dec 2025 was 61,977,408, a 2.1% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Ascendis Pharma A/S Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 61,977,408 +1,287,921 +2.1% 31 Dec 2025 20-F 11 Feb 2026 2025 FY
Q4 2024 60,689,487 +2,982,048 +5.2% 31 Dec 2024 20-F 12 Feb 2025 2024 FY
Q4 2023 57,707,439 +555,144 +0.97% 31 Dec 2023 20-F 07 Feb 2024 2023 FY
Q4 2022 57,152,295 +214,613 +0.38% 31 Dec 2022 20-F 16 Feb 2023 2022 FY
Q4 2021 56,937,682 +3,187,296 +5.9% 31 Dec 2021 20-F 02 Mar 2022 2021 FY
Q4 2020 53,750,386 +5,764,549 +12% 31 Dec 2020 20-F 10 Mar 2021 2020 FY
Q4 2019 47,985,837 +5,850,389 +14% 31 Dec 2019 20-F 03 Apr 2020 2019 FY
Q4 2018 42,135,448 +5,151,156 +14% 31 Dec 2018 20-F 03 Apr 2019 2018 FY
Q4 2017 36,984,292 31 Dec 2017 20-F 28 Mar 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.